Why the study?
Most patients with severe tricuspid regurgitation lack treatment options due to prohibitive surgical risk, highlighting an unmet clinical need for new transcatheter therapies.
Design
Review article
Authors
Loading...
Updates transcatheter TR device landscape for high-risk patients; leaves open which approaches will prove safe and effective.
Transcatheter repair and replacement devices offer emerging treatment options for patients with severe tricuspid regurgitation who are at prohibitive surgical risk.
Curio et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: